Cross-sectional study shows malaria prevalence at 1.0% among migrants in Tripoli, indicating treatment gaps.
Libya, a malaria-free country since 1973, faces reintroduction risks from migrants traversing endemic regions and living in substandard Libyan conditions. A cross-sectional study (February–July 2025) screened 100 adult migrants (94% male, mean age 28.7) in Tripoli, primarily from Nigeria (54%) and Sudan (38%), residing ≤3 years in Libya. Using RDT, microscopy, and PCR, plus surveys, overall malaria prevalence was 1.0% (1/100), with full diagnostic concordance. The single case was an asymptomatic 25-year-old Sudanese male with P. falciparum (residency 6-12 months). The history of malaria infection was higher in Sudanese (35.0%) vs. Nigerians (24.6%), primarily occurring in youth. Recent arrivals (<1 year) reported more symptoms (47.5% vs. 26.2%). Critically, 82% of symptomatic participants had not received any treatment. Despite low prevalence, the asymptomatic carrier highlights treatment gaps and heightened risk among recent migrants.
No takes yet. Share an insight, caveat, or question.
Alsherif et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: